nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—KCNH2—purkinje fiber—dilated cardiomyopathy	0.112	0.337	CbGeAlD
Thioridazine—KCNH2—endocardium—dilated cardiomyopathy	0.0579	0.173	CbGeAlD
Thioridazine—CYP2C9—cardial valve—dilated cardiomyopathy	0.0471	0.141	CbGeAlD
Thioridazine—HTR7—pulmonary artery—dilated cardiomyopathy	0.0252	0.0753	CbGeAlD
Thioridazine—HTR7—sympathetic nervous system—dilated cardiomyopathy	0.0245	0.0733	CbGeAlD
Thioridazine—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.0214	0.065	CcSEcCtD
Thioridazine—Incontinence—Furosemide—dilated cardiomyopathy	0.0184	0.056	CcSEcCtD
Thioridazine—HTR2A—pulmonary artery—dilated cardiomyopathy	0.0157	0.047	CbGeAlD
Thioridazine—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.0153	0.0457	CbGeAlD
Thioridazine—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.0135	0.0409	CcSEcCtD
Thioridazine—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.0106	0.0322	CcSEcCtD
Thioridazine—Eruption—Furosemide—dilated cardiomyopathy	0.0105	0.0318	CcSEcCtD
Thioridazine—Encainide—SCN5A—dilated cardiomyopathy	0.00999	0.408	CrCbGaD
Thioridazine—Moricizine—SCN5A—dilated cardiomyopathy	0.00929	0.379	CrCbGaD
Thioridazine—Lethargy—Spironolactone—dilated cardiomyopathy	0.00877	0.0266	CcSEcCtD
Thioridazine—Cholestasis—Furosemide—dilated cardiomyopathy	0.00848	0.0258	CcSEcCtD
Thioridazine—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.00753	0.0229	CcSEcCtD
Thioridazine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00736	0.0223	CcSEcCtD
Thioridazine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00662	0.0201	CcSEcCtD
Thioridazine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00618	0.0188	CcSEcCtD
Thioridazine—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00605	0.0184	CcSEcCtD
Thioridazine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00533	0.0162	CcSEcCtD
Thioridazine—Trifluoperazine—TNNC1—dilated cardiomyopathy	0.0052	0.213	CrCbGaD
Thioridazine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00496	0.0151	CcSEcCtD
Thioridazine—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.00488	0.0146	CbGeAlD
Thioridazine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00483	0.0147	CcSEcCtD
Thioridazine—Lethargy—Furosemide—dilated cardiomyopathy	0.00477	0.0145	CcSEcCtD
Thioridazine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00463	0.0141	CcSEcCtD
Thioridazine—KCNH2—myocardium—dilated cardiomyopathy	0.00459	0.0137	CbGeAlD
Thioridazine—CHRM2—heart—dilated cardiomyopathy	0.00443	0.0133	CbGeAlD
Thioridazine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00426	0.0129	CcSEcCtD
Thioridazine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00414	0.0126	CcSEcCtD
Thioridazine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.004	0.0122	CcSEcCtD
Thioridazine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.004	0.0121	CcSEcCtD
Thioridazine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00385	0.0117	CcSEcCtD
Thioridazine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00376	0.0114	CcSEcCtD
Thioridazine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00369	0.0112	CcSEcCtD
Thioridazine—Drowsiness—Furosemide—dilated cardiomyopathy	0.0036	0.0109	CcSEcCtD
Thioridazine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00348	0.0106	CcSEcCtD
Thioridazine—HTR7—heart—dilated cardiomyopathy	0.00344	0.0103	CbGeAlD
Thioridazine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00336	0.0102	CcSEcCtD
Thioridazine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00334	0.0101	CcSEcCtD
Thioridazine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00334	0.0101	CcSEcCtD
Thioridazine—ADRA1A—heart—dilated cardiomyopathy	0.00331	0.00992	CbGeAlD
Thioridazine—KCNH2—heart—dilated cardiomyopathy	0.0032	0.00958	CbGeAlD
Thioridazine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00311	0.00946	CcSEcCtD
Thioridazine—Asthma—Lisinopril—dilated cardiomyopathy	0.00303	0.00921	CcSEcCtD
Thioridazine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.003	0.00912	CcSEcCtD
Thioridazine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00295	0.00897	CcSEcCtD
Thioridazine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00289	0.00878	CcSEcCtD
Thioridazine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00289	0.00878	CcSEcCtD
Thioridazine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00288	0.00875	CcSEcCtD
Thioridazine—Erythema—Furosemide—dilated cardiomyopathy	0.00282	0.00856	CcSEcCtD
Thioridazine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00277	0.00841	CcSEcCtD
Thioridazine—Weight increased—Lisinopril—dilated cardiomyopathy	0.00276	0.00838	CcSEcCtD
Thioridazine—KCNH2—cardiac atrium—dilated cardiomyopathy	0.00274	0.00819	CbGeAlD
Thioridazine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00269	0.00816	CcSEcCtD
Thioridazine—Rash—Spironolactone—dilated cardiomyopathy	0.00266	0.00809	CcSEcCtD
Thioridazine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00266	0.00808	CcSEcCtD
Thioridazine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00265	0.00806	CcSEcCtD
Thioridazine—Headache—Spironolactone—dilated cardiomyopathy	0.00265	0.00804	CcSEcCtD
Thioridazine—Jaundice—Lisinopril—dilated cardiomyopathy	0.00264	0.00801	CcSEcCtD
Thioridazine—Anaemia—Furosemide—dilated cardiomyopathy	0.0026	0.00791	CcSEcCtD
Thioridazine—CYP2C9—heart—dilated cardiomyopathy	0.0026	0.00779	CbGeAlD
Thioridazine—Agitation—Furosemide—dilated cardiomyopathy	0.00259	0.00786	CcSEcCtD
Thioridazine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00252	0.00767	CcSEcCtD
Thioridazine—Leukopenia—Furosemide—dilated cardiomyopathy	0.00252	0.00766	CcSEcCtD
Thioridazine—ADRA2A—heart—dilated cardiomyopathy	0.00252	0.00754	CbGeAlD
Thioridazine—Nausea—Spironolactone—dilated cardiomyopathy	0.00251	0.00762	CcSEcCtD
Thioridazine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00239	0.00726	CcSEcCtD
Thioridazine—Confusional state—Furosemide—dilated cardiomyopathy	0.00232	0.00704	CcSEcCtD
Thioridazine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00225	0.00684	CcSEcCtD
Thioridazine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00222	0.00675	CcSEcCtD
Thioridazine—Anorexia—Furosemide—dilated cardiomyopathy	0.00219	0.00666	CcSEcCtD
Thioridazine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00217	0.00659	CcSEcCtD
Thioridazine—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.00216	0.00645	CbGeAlD
Thioridazine—Hypotension—Furosemide—dilated cardiomyopathy	0.00215	0.00652	CcSEcCtD
Thioridazine—HTR2A—heart—dilated cardiomyopathy	0.00214	0.00641	CbGeAlD
Thioridazine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00213	0.00646	CcSEcCtD
Thioridazine—Erythema—Lisinopril—dilated cardiomyopathy	0.00211	0.00642	CcSEcCtD
Thioridazine—Somnolence—Furosemide—dilated cardiomyopathy	0.00204	0.00621	CcSEcCtD
Thioridazine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.002	0.00607	CcSEcCtD
Thioridazine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00199	0.00605	CcSEcCtD
Thioridazine—Tremor—Lisinopril—dilated cardiomyopathy	0.00198	0.00601	CcSEcCtD
Thioridazine—Constipation—Furosemide—dilated cardiomyopathy	0.00197	0.00597	CcSEcCtD
Thioridazine—Anaemia—Lisinopril—dilated cardiomyopathy	0.00195	0.00593	CcSEcCtD
Thioridazine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00193	0.00587	CcSEcCtD
Thioridazine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00189	0.00575	CcSEcCtD
Thioridazine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00189	0.00575	CcSEcCtD
Thioridazine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00182	0.00552	CcSEcCtD
Thioridazine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00174	0.00528	CcSEcCtD
Thioridazine—Oedema—Lisinopril—dilated cardiomyopathy	0.00172	0.00524	CcSEcCtD
Thioridazine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00169	0.00514	CcSEcCtD
Thioridazine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00169	0.00513	CcSEcCtD
Thioridazine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00168	0.00511	CcSEcCtD
Thioridazine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00167	0.00506	CcSEcCtD
Thioridazine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00164	0.00499	CcSEcCtD
Thioridazine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00161	0.0049	CcSEcCtD
Thioridazine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00157	0.00478	CcSEcCtD
Thioridazine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00153	0.00466	CcSEcCtD
Thioridazine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.0015	0.00455	CcSEcCtD
Thioridazine—Constipation—Lisinopril—dilated cardiomyopathy	0.00147	0.00448	CcSEcCtD
Thioridazine—Vomiting—Furosemide—dilated cardiomyopathy	0.00146	0.00444	CcSEcCtD
Thioridazine—Rash—Furosemide—dilated cardiomyopathy	0.00145	0.0044	CcSEcCtD
Thioridazine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00145	0.0044	CcSEcCtD
Thioridazine—Headache—Furosemide—dilated cardiomyopathy	0.00144	0.00437	CcSEcCtD
Thioridazine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00142	0.00432	CcSEcCtD
Thioridazine—Nausea—Furosemide—dilated cardiomyopathy	0.00137	0.00415	CcSEcCtD
Thioridazine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00136	0.00414	CcSEcCtD
Thioridazine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00127	0.00386	CcSEcCtD
Thioridazine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00118	0.00358	CcSEcCtD
Thioridazine—Vomiting—Lisinopril—dilated cardiomyopathy	0.0011	0.00333	CcSEcCtD
Thioridazine—Rash—Lisinopril—dilated cardiomyopathy	0.00109	0.0033	CcSEcCtD
Thioridazine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00109	0.0033	CcSEcCtD
Thioridazine—Headache—Lisinopril—dilated cardiomyopathy	0.00108	0.00328	CcSEcCtD
Thioridazine—Nausea—Lisinopril—dilated cardiomyopathy	0.00102	0.00311	CcSEcCtD
Thioridazine—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	9.9e-05	0.000317	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.87e-05	0.000316	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.86e-05	0.000316	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.85e-05	0.000315	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.84e-05	0.000315	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.76e-05	0.000313	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.76e-05	0.000313	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.69e-05	0.00031	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.66e-05	0.000309	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.6e-05	0.000307	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	9.46e-05	0.000303	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	9.46e-05	0.000303	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.44e-05	0.000302	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.42e-05	0.000302	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	9.41e-05	0.000301	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.36e-05	0.0003	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.27e-05	0.000297	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.25e-05	0.000296	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.1e-05	0.000292	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.08e-05	0.000291	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	9.01e-05	0.000288	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	8.97e-05	0.000287	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.96e-05	0.000287	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	8.94e-05	0.000286	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.94e-05	0.000286	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.86e-05	0.000284	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.82e-05	0.000282	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.8e-05	0.000282	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.79e-05	0.000282	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.77e-05	0.000281	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.72e-05	0.000279	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.71e-05	0.000279	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.68e-05	0.000278	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.59e-05	0.000275	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.47e-05	0.000271	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.45e-05	0.000271	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.44e-05	0.00027	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.43e-05	0.00027	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.4e-05	0.000269	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.4e-05	0.000269	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	8.35e-05	0.000268	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	8.35e-05	0.000268	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.3e-05	0.000266	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.27e-05	0.000265	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.27e-05	0.000265	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.17e-05	0.000262	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.15e-05	0.000261	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.15e-05	0.000261	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	8.07e-05	0.000258	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.05e-05	0.000258	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.02e-05	0.000257	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.01e-05	0.000256	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	8e-05	0.000256	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	8e-05	0.000256	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	8e-05	0.000256	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.81e-05	0.00025	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.78e-05	0.000249	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.77e-05	0.000249	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.75e-05	0.000248	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	7.69e-05	0.000246	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.67e-05	0.000246	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.66e-05	0.000245	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	7.65e-05	0.000245	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.64e-05	0.000245	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.61e-05	0.000244	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.56e-05	0.000242	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.55e-05	0.000242	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.52e-05	0.000241	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.52e-05	0.000241	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.51e-05	0.00024	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.5e-05	0.00024	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.44e-05	0.000238	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.43e-05	0.000238	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.43e-05	0.000238	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.37e-05	0.000236	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.37e-05	0.000236	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	7.32e-05	0.000235	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.32e-05	0.000234	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	7.31e-05	0.000234	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.3e-05	0.000234	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.25e-05	0.000232	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.25e-05	0.000232	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.24e-05	0.000232	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.24e-05	0.000232	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.21e-05	0.000231	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.2e-05	0.000231	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.2e-05	0.000231	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.18e-05	0.00023	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.16e-05	0.000229	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.12e-05	0.000228	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.12e-05	0.000228	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.12e-05	0.000228	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.11e-05	0.000228	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.1e-05	0.000227	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.1e-05	0.000227	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.1e-05	0.000227	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.07e-05	0.000226	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.06e-05	0.000226	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.97e-05	0.000223	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.95e-05	0.000223	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.94e-05	0.000222	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.88e-05	0.00022	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.85e-05	0.00022	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.83e-05	0.000219	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.81e-05	0.000218	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.79e-05	0.000218	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	6.75e-05	0.000216	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.74e-05	0.000216	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.73e-05	0.000216	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.66e-05	0.000213	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	6.64e-05	0.000213	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.64e-05	0.000213	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	6.63e-05	0.000212	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.62e-05	0.000212	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.6e-05	0.000211	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.6e-05	0.000211	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.6e-05	0.000211	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.53e-05	0.000209	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	6.52e-05	0.000209	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.52e-05	0.000209	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	6.51e-05	0.000208	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.46e-05	0.000207	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—RAC1—dilated cardiomyopathy	6.42e-05	0.000206	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.42e-05	0.000206	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—RAC1—dilated cardiomyopathy	6.42e-05	0.000206	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.41e-05	0.000205	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.4e-05	0.000205	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.33e-05	0.000203	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.21e-05	0.000199	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.19e-05	0.000198	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.15e-05	0.000197	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AGT—dilated cardiomyopathy	6.14e-05	0.000197	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.14e-05	0.000196	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AGT—dilated cardiomyopathy	6.13e-05	0.000196	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.13e-05	0.000196	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.12e-05	0.000196	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.09e-05	0.000195	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	6.04e-05	0.000194	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.04e-05	0.000193	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.94e-05	0.00019	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.88e-05	0.000188	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.83e-05	0.000187	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.67e-05	0.000182	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.58e-05	0.000179	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.57e-05	0.000178	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	5.53e-05	0.000177	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.48e-05	0.000175	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.46e-05	0.000175	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.38e-05	0.000172	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.34e-05	0.000171	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.31e-05	0.00017	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.29e-05	0.00017	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.29e-05	0.000169	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	5.28e-05	0.000169	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.28e-05	0.000169	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.26e-05	0.000169	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.24e-05	0.000168	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.2e-05	0.000166	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.18e-05	0.000166	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.08e-05	0.000163	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.07e-05	0.000163	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.01e-05	0.000161	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.94e-05	0.000158	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.94e-05	0.000158	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	4.87e-05	0.000156	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.81e-05	0.000154	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	4.76e-05	0.000152	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	4.74e-05	0.000152	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	4.73e-05	0.000152	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.69e-05	0.00015	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.62e-05	0.000148	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.61e-05	0.000148	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.6e-05	0.000147	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.55e-05	0.000146	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	4.54e-05	0.000146	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.54e-05	0.000145	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	4.53e-05	0.000145	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.53e-05	0.000145	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	4.52e-05	0.000145	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.52e-05	0.000145	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	4.47e-05	0.000143	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.46e-05	0.000143	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.45e-05	0.000143	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	4.36e-05	0.000139	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	4.33e-05	0.000139	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	4.27e-05	0.000137	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—RAF1—dilated cardiomyopathy	4.26e-05	0.000136	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.26e-05	0.000136	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—RAF1—dilated cardiomyopathy	4.26e-05	0.000136	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.2e-05	0.000134	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	4.18e-05	0.000134	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.14e-05	0.000132	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	4.11e-05	0.000132	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.1e-05	0.000131	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	4.03e-05	0.000129	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	4.02e-05	0.000129	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	3.99e-05	0.000128	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	3.93e-05	0.000126	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	3.92e-05	0.000126	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	3.92e-05	0.000125	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	3.87e-05	0.000124	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	3.85e-05	0.000123	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	3.84e-05	0.000123	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	3.76e-05	0.000121	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	3.74e-05	0.00012	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.67e-05	0.000117	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.66e-05	0.000117	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.64e-05	0.000117	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	3.57e-05	0.000114	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.49e-05	0.000112	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	3.45e-05	0.000111	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	3.39e-05	0.000109	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	3.36e-05	0.000108	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.21e-05	0.000103	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	3.17e-05	0.000102	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.16e-05	0.000101	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.16e-05	0.000101	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	3.15e-05	0.000101	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	3.15e-05	0.000101	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	3.14e-05	0.0001	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.1e-05	9.94e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.1e-05	9.92e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	3.09e-05	9.9e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	3.06e-05	9.81e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	3.03e-05	9.69e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	3e-05	9.62e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—EGFR—dilated cardiomyopathy	2.92e-05	9.36e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—EGFR—dilated cardiomyopathy	2.92e-05	9.35e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.88e-05	9.21e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.78e-05	8.91e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	2.77e-05	8.87e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	2.76e-05	8.84e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.72e-05	8.72e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.72e-05	8.71e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	2.69e-05	8.61e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	2.67e-05	8.57e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.67e-05	8.54e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	2.62e-05	8.39e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.51e-05	8.05e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.48e-05	7.94e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	2.36e-05	7.55e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.16e-05	6.93e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	2.15e-05	6.89e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	2.06e-05	6.6e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.9e-05	6.08e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.87e-05	5.98e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.86e-05	5.97e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.83e-05	5.87e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.83e-05	5.86e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.7e-05	5.44e-05	CbGpPWpGaD
